Rockley Photonics Shares Pop On Preliminary Human Studies Results

Rockley Photonics Holdings Ltd (NYSE:RKLY) completed the first stages of its preliminary human studies, examining the measurement of core body temperature using its non-invasive biomarker sensing platform.
Rockley's sensing platform has the potential to provide real-time insights about multiple health conditions by allowing the detection of core body temperature from a wearable device like a smartwatch or wristband.
The Rockley sensing platform uses photonic integrated circuit sensors to generate numerous discrete, narrow-linewidth laser wavelengths across a wide spectral range.
Rockley's in-house core body temperature studies represent the first in a series of studies designed to evaluate and refine the performance of Rockley's biomarker sensing platform in measuring a wide range of biomarkers.
Price Action: RKLY shares traded higher by 8.05% at $5.90 on the last check Wednesday.

To add Benzinga News as your preferred source on Google, click here.